MENU

EVMN Evommune Inc. Forecast, Technical & Fundamental Analysis

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases... Show more

EVMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
EVMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

EVMN is expected to report earnings to rise 21.87% to -77 cents per share on December 10

Evommune Inc. EVMN Stock Earnings Reports
Q3'26
Est.
$-0.78
Q1'26
Beat
by $0.12
The last earnings report on May 08 showed earnings per share of -63 cents, beating the estimate of -75 cents. With 388.92K shares outstanding, the current market capitalization sits at 382.52M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1841 Page Mill Road
Phone
+1 925 247-4481
Employees
48
Web
https://www.evommune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AADEX30.310.25
+0.83%
American Beacon Large Cap Value R5
IHGIX38.94N/A
N/A
Hartford Dividend and Growth A
PGLEX22.78N/A
N/A
Putnam Focused International Equity R6
STRBX23.86N/A
N/A
Sterling Capital Behav Sm Cp Val Eq R6
JABGX13.56N/A
N/A
JHancock Real Estate Securities I
Evommune (EVMN) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com